輸入代號或公司名稱後按 Enter
6496

科懋

-0.05 (-0.20%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
24.6514成交張數本益比1.67股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025898年增 +4.2%
毛利率202540.1%最新一期
營業利益率2025-19.1%最新一期
每股盈餘2025-3.97
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計64.0%61.1%65.3%77.0%78.5%78.1%57.3%60.2%55.7%59.9%
營業毛利(毛損)36.0%38.9%34.7%23.0%21.5%21.9%42.7%39.8%44.3%40.1%
營業毛利(毛損)淨額36.0%38.9%34.7%23.0%21.5%21.9%42.7%39.8%44.3%40.1%
推銷費用10.6%9.7%8.7%7.9%8.2%10.5%25.7%25.9%25.8%30.9%
管理費用7.0%6.7%6.9%6.2%6.4%7.5%15.7%16.1%18.0%17.9%
研究發展費用4.3%3.5%2.3%3.3%4.0%4.2%6.3%8.1%9.7%10.7%
預期信用減損損失(利益)-0.0%-0.1%-0.0%0.3%-0.5%0.1%0.3%-0.3%
營業費用合計21.9%19.9%18.0%17.4%18.6%22.6%47.1%50.3%53.7%59.2%
營業利益(損失)14.0%19.0%16.7%5.6%2.9%-0.7%-4.4%-10.5%-9.4%-19.1%
利息收入0.0%0.0%0.6%0.7%0.4%0.1%
其他收入0.1%0.4%0.2%0.4%0.3%0.1%0.5%0.3%0.5%0.9%
其他利益及損失淨額0.2%0.3%0.0%0.1%0.1%0.1%-0.0%-0.2%-0.7%-0.5%
財務成本淨額0.1%0.0%0.0%0.1%0.1%0.3%0.6%0.8%0.9%0.9%
採用權益法認列之關聯企業及合資損益之份額淨額0.0%0.2%
營業外收入及支出合計0.2%0.6%0.2%0.4%0.3%-0.1%0.5%-0.1%-0.7%-0.1%
稅前淨利(淨損)14.2%19.6%16.9%6.0%3.1%-0.7%-3.9%-10.6%-10.1%-19.2%
所得稅費用(利益)合計2.5%3.3%3.8%1.4%0.7%0.4%1.2%1.2%1.3%1.2%
繼續營業單位本期淨利(淨損)11.8%16.3%13.1%4.6%2.4%-1.2%-5.0%-11.8%-11.5%-20.4%
本期淨利(淨損)11.8%16.3%13.1%4.6%2.4%-1.2%-5.0%-11.8%-11.5%-20.4%
確定福利計畫之再衡量數-0.1%-0.0%-0.0%0.0%0.0%-0.0%0.8%-0.0%0.2%0.0%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-0.1%-0.2%2.0%2.5%1.0%-1.6%-1.9%-0.6%
與不重分類之項目相關之所得稅0.0%0.0%0.0%0.0%0.2%-0.0%0.0%0.0%
不重分類至損益之項目:-0.2%2.0%2.5%1.6%-1.7%-1.7%-0.6%
其他綜合損益(淨額)-0.1%-0.0%-0.1%-0.2%2.0%2.5%1.6%-1.7%-1.7%-0.6%
本期綜合損益總額11.7%16.3%13.0%4.4%4.4%1.3%-3.4%-13.5%-13.1%-21.0%
母公司業主(淨利∕損)11.8%16.3%13.1%4.6%2.4%-1.2%-5.0%-11.8%-11.5%-20.4%
母公司業主(綜合損益)11.7%16.3%13.0%4.4%4.4%1.3%-3.4%-13.5%-13.1%-21.0%
基本每股盈餘0.3%0.3%0.3%0.1%0.1%-0.0%-0.1%-0.3%-0.2%-0.4%
稀釋每股盈餘0.3%0.3%0.3%0.1%0.1%-0.0%-0.1%-0.3%
銷貨收入淨額100.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。